DE MARTIN, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.969
EU - Europa 1.083
AS - Asia 922
AF - Africa 8
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 6.996
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.964
IT - Italia 554
CN - Cina 414
SG - Singapore 340
FI - Finlandia 101
DE - Germania 83
FR - Francia 79
GB - Regno Unito 78
SE - Svezia 74
PK - Pakistan 69
IN - India 25
UA - Ucraina 24
TR - Turchia 18
CH - Svizzera 17
VN - Vietnam 17
RU - Federazione Russa 16
NL - Olanda 15
HK - Hong Kong 12
ES - Italia 8
IE - Irlanda 7
IR - Iran 7
KR - Corea 5
AT - Austria 4
BR - Brasile 4
DK - Danimarca 4
PL - Polonia 4
JP - Giappone 3
MX - Messico 3
NG - Nigeria 3
RS - Serbia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BE - Belgio 2
CA - Canada 2
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
HU - Ungheria 2
KE - Kenya 2
LU - Lussemburgo 2
SA - Arabia Saudita 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
LY - Libia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 6.996
Salva come PNG Salva come JPEG
Città #
Fairfield 843
Woodbridge 515
Chandler 438
Ashburn 368
Ann Arbor 308
Houston 304
Singapore 287
Cambridge 280
Seattle 270
Padova 258
Wilmington 242
Santa Clara 152
Boardman 142
Jacksonville 109
Beijing 99
Princeton 94
San Diego 74
Medford 67
Helsinki 65
Des Moines 51
Roxbury 45
Nanjing 44
Sahiwal 34
New York 32
Jinan 24
Milan 24
Nanchang 21
Shenyang 19
Rome 18
Dong Ket 17
Venice 16
Lahore 14
London 14
Guangzhou 13
Shanghai 13
Ankara 12
Washington 12
Hong Kong 11
Saarbrücken 10
Tianjin 10
Hebei 9
Lugano 9
Rawalpindi 9
Redwood City 9
Bologna 8
Kilburn 8
Los Angeles 8
Treviso 8
Dublin 7
Jiaxing 7
Munich 7
Saint Petersburg 7
Zhengzhou 7
Genova 6
Hounslow 6
Kunming 6
Toba Tek Singh 6
Amsterdam 5
Hefei 5
Mumbai 5
Ogden 5
Binasco 4
Chicago 4
Haikou 4
Hangzhou 4
Melito di Napoli 4
Ningbo 4
Norwalk 4
Pessac 4
Vicenza 4
Aix-en-Provence 3
Aprilia 3
Bergamo 3
Cagliari 3
Camparada 3
Changsha 3
Dallas 3
Detroit 3
Faisalabad 3
Gujrat 3
Ibadan 3
Indiana 3
Kolkata 3
Mexico City 3
Naples 3
Paris 3
Phoenix 3
Pittsburgh 3
Ronco all'Adige 3
San Michele All'adige 3
Sesto Fiorentino 3
São Paulo 3
Taipei 3
Taizhou 3
Talence 3
Vadodara 3
Warsaw 3
Wuhan 3
Zurich 3
Al Ain City 2
Totale 5.641
Salva come PNG Salva come JPEG
Nome #
Live applications of norbormide-based fluorescent probes in Drosophila melanogaster 183
Flavonoids Regulate Lipid Droplets Biogenesis in Drosophila melanogaster 183
The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH 149
Dopamine–mediated immunomodulation affects choroid plexus function 148
Extrahepatic autoimmunity in autoimmune liver disease 145
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes 145
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 141
Novel Super Stealth immunoliposomes for cancer targeted delivery of doxorubicin: an innovative strategy to reduce liver toxicity 127
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis 125
An NBD derivative of the selective rat toxicant norbormide as a new probe for living cell imaging 119
Enzyme inhibition and induction in liver disease. 116
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats 116
Super Stealth immunoliposomes as a strategy to overcome liposome-induced liver toxicity 114
Expression and distribution of the adrenomedullin system in newborn human thymus. 110
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 108
Effect of CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function 106
An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells 106
Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice 106
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in earlyand late-stage cholestasis 102
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 102
The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver 102
In vitro and in vivo behavior of liposomes decorated with PEGs with different chemical features 101
The effect of liver disease on inhibitory and plasma protein-binding displacement interaction:an update. 99
Pharmacokinetic drug interactions in liver disease: An update 99
Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders 99
The activation of NF-kB, Pregnane X Receptor, and Constitutive Androstane Receptor is modulated by the degree of cholestasis 98
Cuban brown propolis interferes in the crosstalk between colorectal cancer cells and m2 macrophages 98
Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation 97
Etiopathogenesis of autoimmune hepatitis 94
NAD+-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis. 93
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis 91
The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells. 91
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients 90
Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat. 87
P383 EFFECT OF PREGNANE X RECEPTOR (PXR) AND CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) ON CYTOCHROME P3A ENZYMES IN AN EXPERIMENTAL MODEL OF CHOLESTASIS 87
Depression and cognitive impairment-Extrahepatic manifestations of NAFLD and NASH 86
The ecto-enzymes CD73 and adenosine deaminase modulate 5′-AMP-derived adenosine in myofibroblasts of the rat small intestine 85
Refill liquids for electronic cigarettes display peculiar toxicity on human endothelial cells 84
Irreversible CYP3A Inhibition Accompained by Plasma Protein-Binding Displacement: A Comparative Analysis in Subjects with normal and impaired liver function. 82
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 82
Emerging players in liver fibrosis regression in a chronic murine model of hepatic injury 81
Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats 80
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure 77
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 77
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis 75
Expression of adrenomedullin in chronic inflammatory liver diseases 74
PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma 73
Effect of renal flailure on metabolic disposition of lidocaine in patients undergoing and not undergoing hemodialysis 69
null 69
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 68
How gender influences fibrosis regression in a chronic murine model of hepatic injury 68
Farmaci citotossici 66
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment 66
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: analysis on cytokines and lipid profile 65
Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats. 63
Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients 62
Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases 62
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 62
Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells 60
Enzyme induction is independent on liver functional status 59
EXPRESSION OF ADRENOMEDULLIN AND ITS RECEPTOR IN HUMAN THYMUS 57
Drosophila REEP1 modulates ER morphology and ER stress 56
Folic acid-targeted paclitaxel-polymer conjugates exert selective cytotoxicity and modulate invasiveness of colon cancer cells 55
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial 53
In vitro inhibition of cytochrome P450 (CYP) 2C8-mediated drug metabolism by the flavonoid diosmetin 51
Fluvoxamine pharmacokinetics in elderly subjects and patients with chronic heart failure 50
Anti-HER2 Super Stealth Immunoliposomes for Targeted-Chemotherapy 49
EFFECT OF PREGNANE X RECEPTOR (PXR) AND CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) ON CYTOCHROME P3A ENZYMES IN AN EXPERIMENTAL MODEL OF CHOLESTASIS 48
The balance between fibrosis and regeneration in chronic liver injury: The role of gender 48
The role of oxidative stress in nafld–nash–hcc transition—focus on nadph oxidases 44
Effect of experimentally induced liver cirrhosis on CYP3A induction in male Wistar rats 43
Differential effect of liver dysfunction on CYP3A1 and CYP3A2 expression in rats with carbon tetrachloride-induced cirrhosis 43
Ciprofloxacin treatment affects the structure and activity of enteric nervous system in mouse small intestine 43
Expression and localization of adrenomedullin and its receptor RAMP2 in human thymus 40
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH 39
Effect of CYP 3A4 inhibition on lidocaine kinetics and the MEGS liver function test 39
PCSK9 promotes arterial medial calcification 39
Primary biliary cholangitis: Perception and expectation of illness in Italian patients 37
Gut microbial profiling as a therapeutic and diagnostic target for managing primary biliary cholangitis 36
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 33
REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study 32
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis 29
Esmethadone-HCl (REL-1017): a promising rapid antidepressant 29
Principi generali di chemioterapia antineoplastica 29
In Vitro and In Vivo Sucrosomial® Berberine Activity on Insulin Resistance 27
The nuclear receptor PXR in chronic liver disease 24
Treatment of primary sclerosing cholangitis 22
The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD 22
The Role of Sex in Acute and Chronic Liver Damage 21
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 21
Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates 18
Sex Drives Functional Changes in the Progression and Regression of Liver Fibrosis 16
Tyrosol attenuates NASH features by reprogramming the hepatic immune milieu 14
Update on the Pharmacological Treatment of Primary Biliary Cholangitis 11
Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers 11
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users 9
Obeticholic Acid for Primary Biliary Cholangitis 9
COVID-19 and Autoimmune Liver Diseases 9
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases 8
Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone’ 8
Totale 7.044
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.374
article - articoli 29.073
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 340
Totale 61.787
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020692 0 0 0 0 0 0 105 143 176 129 98 41
2020/20211.003 66 60 124 92 37 54 29 86 144 100 129 82
2021/20221.170 62 107 102 62 88 110 53 111 73 76 82 244
2022/20231.034 172 121 25 95 133 123 73 79 99 15 64 35
2023/2024665 29 89 69 56 52 90 55 30 33 22 56 84
2024/2025924 18 196 150 116 309 133 2 0 0 0 0 0
Totale 7.125